BAYER AKTIENGESELLSCHAFT «...678910...» Page 7 out of 137 from 01/07/1988 to 12/09/2024 The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish 26/02/2019 14:16 BAYER AKTIENGESELLSCHAFT Information on dividends Bayer proposes dividend for 2018 of 2.80 euros per share Register number: 275140 15/02/2019 16:53 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Bayer exercised option to obtain full licensing rights for larotrectinib and BAY 2731954 (LOXO-195) Register number: 274763 15/02/2019 08:14 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Bayer’s darolutamide plus androgen deprivation therapy (ADT) significantly extends metastasis-free survival with a favorable safety profile compared to placebo plus ADT in non-metastatic castration-resistant prostate cancer Register number: 274736 13/02/2019 11:52 BAYER AKTIENGESELLSCHAFT Information on P&L Bayer: Calendario previsto presentación resultados Q4 2018 Register number: 274688 08/01/2019 17:13 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Bayer expands digital innovation pipeline at The Climate Corporation to bring breakthrough digital tools to more farmers Register number: 273579 20/12/2018 09:13 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Bayer receives approval in China for endometriosis treatment Visanne™ Register number: 272946 18/12/2018 13:39 BAYER AKTIENGESELLSCHAFT Loans, credit lines and guarantees Bayer extends credit line and increases volume to 4.5 billion euros Register number: 272767 05/12/2018 10:11 BAYER AKTIENGESELLSCHAFT Information on P&L Bayer to drive value creation as company pursues ambitious growth targets through 2022 Register number: 272130 29/11/2018 15:04 BAYER AKTIENGESELLSCHAFT Information on P&L Bayer to strengthen core life science businesses while significantly enhancing productivity and profitability Register number: 272007 27/11/2018 15:52 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Bayer receives EU approval for its hemophilia A treatment Jivi® Register number: 271945 Page 7 out of 137 «...678910...»